ApoNow

Wetter, Germany Founded: 2014 • Age: 12 yrs Acquired By The Platform Group
Online pharmacy for the purchase of medicines

About ApoNow

ApoNow is a Healthcare company based in Wetter (Germany) founded in 2014, and was acquired by The Platform Group in March 2024. Its chief executive, as recorded, is Thomas Engels. ApoNow offers products and services including Online Ordering Platform. Its focus areas include HealthTech, Healthcare Booking Platforms, Pharmacies and Drugs. Its legal entity is ApoNow GmbH. Its competitors include MAYD, medpex and Axiogenesis; 1 of its 3 listed competitors has raised funding.

Company details

Online pharmacy for the purchase of medicines. The platform allow customers to order online and buy locally from various pharmacies. It also serves as a tool for pharmaceutical manufacturers, allowing visitors to order products directly in a local pharmacy.

  • Headquarters Wetter, Germany
  • Stage Acquired
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website aponow.de
  • Social LinkedIn
  • Acquired by The Platform Group (Mar 2024)
  • Legal Name Aponow Gmbh
Key Metrics

Products & Services of ApoNow

ApoNow offers a comprehensive portfolio of products and services, including Online Ordering Platform.

Online Ordering Platform
Ecommerce Platform

Platform for ordering pharmacy products online with local pickup.

Investors in ApoNow

ApoNow has secured backing from 1 investor. Prominent investors backing the company include The Platform Group.

All
InvestorDescriptionFounded YearDomainLocation
E-commerce consulting services are provided by The Platform Group.
1882the-platform-group.comWiesbaden, Germany
Premium access

Investor details for ApoNow

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of ApoNow

1 people are tracked at ApoNow (1 in leadership).

NameRoleGroup
Thomas Engels
CEOLeadership
Premium access

Complete people profiles for ApoNow

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Timeline of ApoNow

2 dated milestones of ApoNow across 10 years, from founding to its latest funding, stage changes and deals.

  1. Founded ApoNow is founded.
  2. Exit Acquired by The Platform Group.

Competitors of ApoNow

ApoNow has 3 listed competitors in our database, 1 of them funded. They include MAYD, medpex and Axiogenesis.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
getmayd.com2018Berlin, Germany$48.88M
Non-prescription medicines are ordered and delivered online.
medpex.de2005Ludwigshafen, Germany
Medicines for health conditions are sold online by medpex.
axiogenesis.com2000Cologne, Germany
Generic medicines are sold via an online pharmacy platform.
Premium access

Detailed competitors of ApoNow

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of ApoNow

The website of ApoNow (aponow.de) receives about 1.8K visits a month.

  • Monthly visits
    1.8K

    ▲ 3% vs previous month

Similar websites

Websites whose visitors overlap most with ApoNow. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
apo-rot.de
100%
View details
aponeo.de
aponeo.de
100%
#56,132–
eurapon.de
100%
View details
healthcaremarketing.eu
healthcaremarketing.eu
55%
#1,766,410–
apotheke-adhoc.de
apotheke-adhoc.de
52%
#29,969–
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Aponow

The Platform Group acquires further Aponov shares
Finanznachrichten β€’ 2 years ago
Premium access

Complete news archive for ApoNow

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about ApoNow

ApoNow was founded in 2014.

ApoNow is headquartered in Wetter, Germany. It is registered at Wetter, Hesse, Germany.

Thomas Engels is the CEO of ApoNow, as recorded in our data.

Online pharmacy for the purchase of medicines. The platform allow customers to order online and buy locally from various pharmacies. It also serves as a tool for pharmaceutical manufacturers, allowing visitors to order products directly in a local pharmacy.

ApoNow's top competitors include MAYD, medpex and Axiogenesis.

ApoNow offers Online Ordering Platform.

ApoNow has 1 investor. Key investors include The Platform Group.

ApoNow operates through Aponow Gmbh.

Yes. ApoNow was acquired by The Platform Group in March 2024.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available